One of the most difficult things about quitting opioids is how difficult it can be to stop using the substance. Opioid withdrawal comes with a plethora of uncomfortable side effects that can lead people to continue using to avoid them. Even if people quit sober, many end up relapsing due to the strong cravings.
Fortunately, Sublocade treatment is an innovative medication used in the treatment of opioid addiction. It represents a significant advancement in addiction medicine, offering a new approach to managing opioid dependency. At Etowah Recovery Center, we provide Sublocade treatment as an evidence-based Medication-Assisted Treatment component at our rehab in Atlanta.
Sublocade is primarily used to treat opioid use disorder (OUD). It helps reduce the cravings and withdrawal symptoms associated with opioid addiction, enabling individuals to focus on their recovery journey.
Sublocade works by diminishing the intense cravings often experienced by individuals with opioid addiction. By alleviating these cravings, it helps patients focus more on their recovery and less on the compulsion to use opioids, in addition to:
While both Sublocade and Suboxone contain buprenorphine, their forms and modes of administration differ. Suboxone is a daily medication taken orally, combining buprenorphine with naloxone. Sublocade, on the other hand, is a monthly injection, offering a more consistent delivery of medication.
In addition, Sublocade contains buprenorphine as its active ingredient. It is an extended-release injectable formulation designed to release a steady dose of buprenorphine over a month. Suboxone is combination of buprenorphine and naloxone. Buprenorphine reduces withdrawal symptoms and cravings, while naloxone is included to deter misuse (since it can precipitate withdrawal symptoms if Suboxone is injected).
Vivitrol, another medication used in addiction treatment, contains naltrexone, an opioid antagonist. Unlike Sublocade, which partially activates opioid receptors, Vivitrol completely blocks them. Vivitrol is also administered as a monthly injection.
Common side effects of Sublocade include:
Sublocade has a long-lasting effect due to its extended-release formulation. Its active ingredient, buprenorphine, can remain in the body for weeks to months after the last injection, depending on various factors like metabolism and dosage.
Sublocade’s effectiveness has been evaluated through various clinical studies, showing promising results in treating opioid use disorder (OUD). One key study from the FDA found that Sublocade-treated patients had higher abstinence rates and better control over craving and withdrawal symptoms compared to those receiving a placebo.
For those seeking addiction treatment in Atlanta, Etowah Recovery offers comprehensive care tailored to individual needs. Call now at 404-640-5825 or verify your insurance learn more about our programs and start your journey towards recovery.